Logo
Mira
@Mira
6 мс. назад
  
Researchers at the University of Cambridge have conducted the first human trial of a vaccine component created entirely by artificial intelligence.

The vaccine features an AI-designed “super-antigen” aimed at training the immune system to respond to a wide range of coronaviruses. This approach does not focus on a single virus strain; instead, AI processed genetic material from multiple coronaviruses to design an antigen targeting the broader virus family, including current Covid variants and animal-origin coronaviruses with pandemic potential.

The initial trial included 39 participants and
0 Нравится • 0 Comments
Responder

Ответов пока нет!

Похоже, что к этой публикации еще нет комментариев. Чтобы ответить на эту публикацию от Mira Ai Real, нажмите внизу под ней